Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
XiaoJin Sun, Yang Deng, PengXin Ge, Qiang Peng, Ismatullah Soufiany, Lin Zhu & Rui Duan. (2023) Diminazene Ameliorates Neuroinflammation by Suppression of Astrocytic miRNA-224-5p/NLRP3 Axis in Alzheimer’s Disease Model. Journal of Inflammation Research 16, pages 1639-1652.
Read now
Read now
Kamila Borowiec & Agnieszka Michalak. (2022) Flavonoids from edible fruits as therapeutic agents in neuroinflammation – a comprehensive review and update. Critical Reviews in Food Science and Nutrition 62:24, pages 6742-6760.
Read now
Read now
Vincent Hede & Cédric Devillé. (2019) Treating psychiatric symptoms and disorders with
non-psychotropic medications
. Dialogues in Clinical Neuroscience 21:2, pages 193-201.
Read now
Read now
Faizul Azam, Nada Hussin Alabdullah, Hadeel Mohammed Ehmedat, Abdullah Ramadan Abulifa, Ismail Taban & Sreedevi Upadhyayula. (2018) NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies. Journal of Biomolecular Structure and Dynamics 36:8, pages 2099-2117.
Read now
Read now
Articles from other publishers (44)
Ziyuan Li, Hui Wang & Yafu Yin. (2023) Peripheral inflammation is a potential etiological factor in Alzheimer’s disease. Reviews in the Neurosciences 0:0.
Crossref
Crossref
Xiao-ying Sun, Xiao-lin Yu, Jie Zhu, Ling-jie Li, Lun Zhang, Ya-ru Huang, Dong-qun Liu, Mei Ji, Xun Sun, Ling-xiao Zhang, Wei-wei Zhou, Dongming Zhang, Jianwei Jiao & Rui-tian Liu. (2023) Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer’s disease-like mouse model. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process
417
511
.
Charles H Wallace, Giovanni Oliveros, Peter A Serrano, Patricia Rockwell, Lei Xie & Maria Figueiredo-Pereira. (2022) Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer’s model. Life Science Alliance 5:12, pages e202201555.
Crossref
Crossref
Ahmed B. Montaser, Janita Kuiri, Teemu Natunen, Pavel Hruška, David Potěšil, Seppo Auriola, Mikko Hiltunen, Tetsuya Terasaki, Marko Lehtonen, Aaro Jalkanen & Kristiina M. Huttunen. (2022) Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice. Life Sciences 310, pages 121088.
Crossref
Crossref
Sara Mahdiabadi, Sara Momtazmanesh, George Perry & Nima Rezaei. (2022) Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review. Reviews in the Neurosciences 33:4, pages 365-381.
Crossref
Crossref
Michal Schwartz & Liora Cahalon. (2022) The vicious cycle governing the brain–immune system relationship in neurodegenerative diseases. Current Opinion in Immunology 76, pages 102182.
Crossref
Crossref
Benita Wiatrak, Paulina Jawień, Agnieszka Matuszewska, Adam Szeląg & Adriana Kubis-Kubiak. (2022) Effect of amyloid-β on the redox system activity in SH-SY5Y cells preincubated with lipopolysaccharide or co-cultured with microglia cells. Biomedicine & Pharmacotherapy 149, pages 112880.
Crossref
Crossref
Changmao Wang, Yaqin Wang, Haitang Xie, Cuijiao Zhan, Xuejun He, Ran Liu, Rongfeng Hu, Jie Shen & Yuanwei Jia. (2021) Establishment and validation of an SIL‐IS LC–MS/MS method for the determination of ibuprofen in human plasma and its pharmacokinetic study. Biomedical Chromatography 36:3.
Crossref
Crossref
Tao Liang, Yang Zhang, Suyuan Wu, Qingjie Chen & Lin Wang. (2022) The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets. Frontiers in Pharmacology 13.
Crossref
Crossref
Md Afroz Ahmad, Ozaifa Kareem, Mohammad Khushtar, Md Akbar, Md Rafiul Haque, Ashif Iqubal, Md Faheem Haider, Faheem Hyder Pottoo, Fatima S. Abdulla, Mahia B. Al-Haidar & Noora Alhajri. (2022) Neuroinflammation: A Potential Risk for Dementia. International Journal of Molecular Sciences 23:2, pages 616.
Crossref
Crossref
Raafat A. Abdel-Aal, Ola A. Hussein, Reham G. Elsaady & Lobna A. Abdelzaher. (2022) Naproxen as a potential candidate for promoting rivastigmine anti-Alzheimer activity against aluminum chloride-prompted Alzheimer's-like disease in rats; neurogenesis and apoptosis modulation as a possible underlying mechanism. European Journal of Pharmacology 915, pages 174695.
Crossref
Crossref
Danko Jeremic, Lydia Jiménez-Díaz & Juan D. Navarro-López. (2021) Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review. Ageing Research Reviews 72, pages 101496.
Crossref
Crossref
Rishika Dhapola, Subhendu Shekhar Hota, Phulen Sarma, Anusuya Bhattacharyya, Bikash Medhi & Dibbanti HariKrishna Reddy. (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease. Inflammopharmacology 29:6, pages 1669-1681.
Crossref
Crossref
Fei Chen, Dan Yang, Xiao-Yu Cheng, Hui Yang, Xin-He Yang, He-Tao Liu, Rui Wang, Ping Zheng, Yao Yao & Juan Li. (2021) Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer’s Disease Mouse Model <i>via</i> Inhibition of Microglial Activation and NADPH Oxidase Expression. Biological and Pharmaceutical Bulletin 44:11, pages 1688-1696.
Crossref
Crossref
Abdul Samad Basheer, Faridah Abas, Iekhsan Othman & Rakesh Naidu. (2021) Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications. Cancers 13:16, pages 4226.
Crossref
Crossref
Laura Tiozzo Fasiolo, Michele Dario Manniello, Sabrina Banella, Laura Napoli, Fabrizio Bortolotti, Eride Quarta, Paolo Colombo, Evangelos Balafas, Nikolaos Kostomitsopoulos, Dimitrios M. Rekkas, Georgia Valsami, Paraskevi Papakyriakopoulou, Gaia Colombo & Paola Russo. (2021) Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation. International Journal of Pharmaceutics 605, pages 120827.
Crossref
Crossref
Kiri T. Granger & Jennifer H. Barnett. (2021) Postoperative cognitive dysfunction: an acute approach for the development of novel treatments for neuroinflammation. Drug Discovery Today 26:5, pages 1111-1114.
Crossref
Crossref
Robin M. Voigt, Shohreh Raeisi, Jingyun Yang, Sue Leurgans, Christopher B. Forsyth, Aron S. Buchman, David A. Bennett & Ali Keshavarzian. (2021) Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer’s disease. PLOS ONE 16:3, pages e0240342.
Crossref
Crossref
Jamie Talan. (2021) Key Immune System Molecules Are a Potential Target for Alzheimer's Disease. Neurology Today 21:5, pages 1,32-34.
Crossref
Crossref
Ali mohammadkhanizadeh & fariba karimzadeh. (2021) COVID-19 and Alzheimer's Disease: A Review of Mechanisms and Pathophysiology. The Neuroscience Journal of Shefaye Khatam 9:2, pages 151-159.
Crossref
Crossref
Jimin Yu, Eunbi Cho, Huiyoung Kwon, Jieun Jeon, Jae Seong Sin, Jun Kwon Park, Ji-Su Kim, Ji Woong Choi, Se Jin Park, Mira Jun, Young Choon Lee, Jong Hoon Ryu, Jeongwon Lee, Minho Moon, Seungheon Lee, Jong Hyun Cho & Dong Hyun Kim. (2021) Akt and calcium-permeable AMPA receptor are involved in the effect of pinoresinol on amyloid β-induced synaptic plasticity and memory deficits. Biochemical Pharmacology 184, pages 114366.
Crossref
Crossref
So Yamamoto, Tomoko Kayama, Moeko Noguchi-Shinohara, Tsuyoshi Hamaguchi, Masahito Yamada, Keiko Abe & Shoko Kobayashi. (2021) Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway. npj Science of Food 5:1.
Crossref
Crossref
Nicole Kemberly R. Rocha, Rafael Themoteo, Helena Brentani, Orestes V. Forlenza & Vanessa De Jesus Rodrigues De Paula. (2020) Neuronal–Glial Interaction in a Triple-Transgenic Mouse Model of Alzheimer’s Disease: Gene Ontology and Lithium Pathways. Frontiers in Neuroscience 14.
Crossref
Crossref
Sharon Melamed, Roy Avraham, Deborah E. Rothbard, Noam Erez, Tomer Israely, Ziv Klausner, Anthony H. Futerman, Nir Paran & Einat B. Vitner. (2020) Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis. Acta Neuropathologica Communications 8:1.
Crossref
Crossref
Nurul Husna Ibrahim, Mohamad Fairuz Yahaya, Wael Mohamed, Seong Lin Teoh, Chua Kien Hui & Jaya Kumar. (2020) Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty. Frontiers in Pharmacology 11.
Crossref
Crossref
Samuel F. Yanuck. (2019) Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders. Frontiers in Psychiatry 10.
Crossref
Crossref
Fan Hong, Shijia Pan, Yuan Guo, Pengfei Xu & Yonggong Zhai. (2019) PPARs as Nuclear Receptors for Nutrient and Energy Metabolism. Molecules 24:14, pages 2545.
Crossref
Crossref
Ryszard Pluta & Marzena Ułamek-Kozioł. 2019. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders
71
82
.
Áine M. Kelly. (2018) Exercise-Induced Modulation of Neuroinflammation in Models of Alzheimer’s Disease. Brain Plasticity 4:1, pages 81-94.
Crossref
Crossref
Jie Feng, Jing‐Xue Wang, Ye‐Hong Du, Ying Liu, Wei Zhang, Jing‐Fei Chen, Yuan‐Jie Liu, Min Zheng, Ke‐Jian Wang & Gui‐Qiong He. (2018)
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing
NLRP
3 inflammasome activation in
APP
/
PS
1 transgenic mice
. CNS Neuroscience & Therapeutics 24:12, pages 1207-1218.
Crossref
Crossref
Camilla Thygesen, Laura Ilkjær, Stefan J. Kempf, Anne Louise Hemdrup, Christian Ulrich von Linstow, Alicia A. Babcock, Sultan Darvesh, Martin R. Larsen & Bente Finsen. (2018) Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APPSWE/PS1ΔE9 Transgenic Mice Implicate Cathepsin Z in Alzheimer’s Disease. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref
Sid E. O’Bryant, Fan Zhang, Leigh A. Johnson, James Hall, Melissa Edwards, Paula Grammas, Esther Oh, Constantine G. Lyketsos & Robert A. Rissman. (2018) A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer’s Disease. Journal of Alzheimer's Disease 66:1, pages 97-104.
Crossref
Crossref
Andrew J. Doig. (2018) Positive Feedback Loops in Alzheimer’s Disease: The Alzheimer’s Feedback Hypothesis. Journal of Alzheimer's Disease 66:1, pages 25-36.
Crossref
Crossref
Qing‑Fang Gu, Jie‑Zhong Yu, Hao Wu, Yan‑Hua Li, Chun-Yun Liu, Ling Feng, Guang‑Xian Zhang, Bao‑Guo Xiao & Cun‑Gen Ma. (2018) Therapeutic effect of Rho kinase inhibitor FSD‑C10 in a mouse model of Alzheimer's disease. Experimental and Therapeutic Medicine.
Crossref
Crossref
S.O. Bachurin, E.V. Bovina & A.A. Ustyugov. (2018) Current Trends in the Development of Drugs for the Treatment of Alzheimer’s Disease and their Clinical Trials. Biomedical Chemistry: Research and Methods 1:3, pages e00015.
Crossref
Crossref
Maria Valeria CataniValeria GasperiTiziana BisognoMauro Maccarrone. (2018) Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases. Antioxidants & Redox Signaling 29:1, pages 37-60.
Crossref
Crossref
Rodrigo Zanandrea, Murilo S. Abreu, Angelo Piato, Leonardo J.G. Barcellos & Ana C.V.V. Giacomini. (2018) Lithium prevents scopolamine-induced memory impairment in zebrafish. Neuroscience Letters 664, pages 34-37.
Crossref
Crossref
Ka Sing P Lai, Celina S Liu, Allison Rau, Krista L Lanctôt, Cristiano A Köhler, Maureen Pakosh, André F Carvalho & Nathan Herrmann. (2017) Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies. Journal of Neurology, Neurosurgery & Psychiatry 88:10, pages 876-882.
Crossref
Crossref
Hadijat M. Makinde, Talia B. Just, Carla M. Cuda, Harris Perlman & Steven J. Schwulst. (2017) The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy. Shock 48:3, pages 276-283.
Crossref
Crossref
Sergey O. Bachurin, Elena V. Bovina & Aleksey A. Ustyugov. (2017) Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends. Medicinal Research Reviews 37:5, pages 1186-1225.
Crossref
Crossref
Eileen M. Burd & Lars F. Westblade. 2017. The Dark Art of Blood Cultures. The Dark Art of Blood Cultures
277
295
.
Hadas Keren-Shaul, Amit Spinrad, Assaf Weiner, Orit Matcovitch-Natan, Raz Dvir-Szternfeld, Tyler K. Ulland, Eyal David, Kuti Baruch, David Lara-Astaiso, Beata Toth, Shalev Itzkovitz, Marco Colonna, Michal Schwartz & Ido Amit. (2017) A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease. Cell 169:7, pages 1276-1290.e17.
Crossref
Crossref
Anna Mietelska-Porowska & Urszula Wojda. (2017) T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer’s Disease: Potential Pools of New Biomarkers. Journal of Immunology Research 2017, pages 1-17.
Crossref
Crossref